Genomic and phenotypic comparison of environmental and patient-derived isolates of Pseudomonas aeruginosa suggest that antimicrobial resistance is rare within the environment

References

1. Gellatly SL, Hancock REW. Pseudomonas aeruginosa: new insights into pathogenesis and host defenses. Pathog Dis 2013; 67:159–173 [View Article]
   [Google Scholar]
2. Elborn JS. Cystic fibrosis. Lancet 2016; 388:2519–2531 [View Article]
   [Google Scholar]
3. Lister PD, Wolter DJ, Hanson ND. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev 2009; 22:582–610 [View Article]
   [Google Scholar]
4. Decraene V, Ghebrehewet S, Dardamissis E, Huyton R, Mortimer K et al. An outbreak of multidrug-resistant Pseudomonas aeruginosa in a burns service in the North of England: challenges of infection prevention and control in a complex setting. J Hosp Infect 2018; 100:e239–e245 [View Article]
   [Google Scholar]
5. Kidd TJ, Ritchie SR, Ramsay KA, Grimwood K, Bell SC et al. Pseudomonas aeruginosa exhibits frequent recombination, but only a limited association between genotype and ecological setting. PLoS One 2012; 7:e44199 [View Article]
   [Google Scholar]
6. Purdy-Gibson ME, France M, Hundley TC, Eid N, Remold SK. Pseudomonas aeruginosa in CF and non-CF homes is found predominantly in drains. J Cyst Fibros 2015; 14:341–346 [View Article]
   [Google Scholar]
7. Bhuiya M, Sarkar MKI, Sohag MH, Ali H, Roy CK et al. Enumerating Antibiotic Susceptibility Patterns of Pseudomonas aeruginosa Isolated from Different Sources in Dhaka City. Open Microbiol J 2018; 12:172–180 [View Article]
   [Google Scholar]
8. Devarajan N, Köhler T, Sivalingam P, van Delden C, Mulaji CK et al. Antibiotic resistant Pseudomonas spp. in the aquatic environment: a prevalence study under tropical and temperate climate conditions. Water Res 2017; 115:256–265 [View Article]
   [Google Scholar]
9. Ebrahimpour M, Nikokar I, Ghasemi Y, Sedigh Ebrahim-Saraie H, Araghian A et al. Antibiotic resistance and frequency of class 1 integrons among Pseudomonas aeruginosa isolates obtained from wastewaters of a burn center in Northern Iran. Ann Ig 2018; 30:112–119 [View Article]
   [Google Scholar]
10. Kümmerer K. Antibiotics in the aquatic environment-a review-part II. Chemosphere 2009; 75:435–441 [View Article]
    [Google Scholar]
11. Odumosu BT, Ajetunmobi O, Dada-Adegbola H, Odutayo I. Antibiotic susceptibility pattern and analysis of plasmid profiles of Pseudomonas aeruginosa from human, animal and plant sources. Springerplus 2016; 5:1381 [View Article]
    [Google Scholar]
12. Olga P, Apostolos V, Alexis G, George V, Athena M. Antibiotic resistance profiles of Pseudomonas aeruginosa isolated from various Greek aquatic environments. FEMS Microbiol Ecol 2016; 92:fiw042 [View Article]
    [Google Scholar]
13. Ruiz Lı́dia, Domı́nguez MA, Ruiz N, Viñas M. Relationship between clinical and environmental isolates of Pseudomonas aeruginosa in a hospital setting. Arch Med Res 2004; 35:251–257 [View Article]
    [Google Scholar]
14. Spindler A, Otton LM, Fuentefria DB, Corção G. Beta-Lactams resistance and presence of class 1 integron in Pseudomonas spp. isolated from untreated Hospital effluents in Brazil. Antonie Van Leeuwenhoek 2012; 102:73–81 [View Article]
    [Google Scholar]
15. Tuméo E, Gbaguidi-Haore H, Patry I, Bertrand X, Thouverez M et al. Are antibiotic-resistant Pseudomonas aeruginosa isolated from hospitalised patients recovered in the hospital effluents?. Int J Hyg Environ Health 2008; 211:200–204 [View Article]
    [Google Scholar]
16. Walsh TR, Weeks J, Livermore DM, Toleman MA. Dissemination of NDM-1 positive bacteria in the new Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis 2011; 11:355–362 [View Article]
    [Google Scholar]
17. Schiavano GF, Carloni E, Andreoni F, Magi S, Chironna M et al. Prevalence and antibiotic resistance of Pseudomonas aeruginosa in water samples in central Italy and molecular characterization of oprD in imipenem resistant isolates. PLoS One 2017; 12:e0189172 [View Article]
    [Google Scholar]
18. Gad GF, El-Domany RA, Zaki S, Ashour HM. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms. J Antimicrob Chemother 2007; 60:1010–1017 [View Article]
    [Google Scholar]
19. Kidd TJ, Ramsay KA, Vidmar S, Carlin JB, Bell SC et al. Pseudomonas aeruginosa genotypes acquired by children with cystic fibrosis by age 5-years. J Cyst Fibros 2015; 14:361–369 [View Article]
    [Google Scholar]
20. Ranganathan SC, Skoric B, Ramsay KA, Carzino R, Gibson A-M et al. Geographical differences in first acquisition of Pseudomonas aeruginosa in cystic fibrosis. Ann Am Thorac Soc 2013; 10:108–114 [View Article]
    [Google Scholar]
21. Rosenfeld M, Emerson J, McNamara S, Thompson V, Ramsey BW et al. Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort. J Cyst Fibros 2012; 11:446–453 [View Article]
    [Google Scholar]
22. Römling U, Wingender J, Müller H, Tümmler B. A major Pseudomonas aeruginosa clone common to patients and aquatic habitats. Appl Environ Microbiol 1994; 60:1734–1738
    [Google Scholar]
23. Kittinger C, Lipp M, Baumert R, Folli B, Koraimann G et al. Antibiotic resistance patterns of Pseudomonas spp. isolated from the river Danube. Front Microbiol 2016; 7:586 [View Article]
    [Google Scholar]
24. Liew SM, Rajasekaram G, Puthucheary SA, Chua KH. Antimicrobial susceptibility and virulence genes of clinical and environmental isolates of Pseudomonas aeruginosa . PeerJ 2019; 7:e6217 [View Article]
    [Google Scholar]
25. Anuj SN, Whiley DM, Kidd TJ, Bell SC, Wainwright CE et al. Identification of Pseudomonas aeruginosa by a duplex real-time polymerase chain reaction assay targeting the ecfX and the gyrB genes. Diagn Microbiol Infect Dis 2009; 63:127–131 [View Article]
    [Google Scholar]
26. Jolley KA, Bray JE, Maiden MCJ. Open-Access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications. Wellcome Open Res 2018; 3:124 [View Article]
    [Google Scholar]
27. Matsuda K, Tsuji H, Asahara T, Kado Y, Nomoto K. Sensitive quantitative detection of commensal bacteria by rRNA-targeted reverse transcription-PCR. Appl Environ Microbiol 2007; 73:32–39 [View Article]
    [Google Scholar]
28. Bassetti M, Vena A, Croxatto A, Righi E, Guery B. How to manage Pseudomonas aeruginosa infections. Drugs Context 2018; 7:1–18 [View Article]
    [Google Scholar]
29. Freschi L, Vincent AT, Jeukens J, Emond-Rheault J-G, Kukavica-Ibrulj I et al. The Pseudomonas aeruginosa pan-genome provides new insights on its population structure, horizontal gene transfer, and pathogenicity. Genome Biol Evol 2019; 11:109–120 [View Article]
    [Google Scholar]
30. Choi Y, Sims GE, Murphy S, Miller JR, Chan AP. Predicting the functional effect of amino acid substitutions and indels. PLoS One 2012; 7:e46688 [View Article]
    [Google Scholar]
31. Camacho C, Coulouris G, Avagyan V, Ma N, Papadopoulos J et al. BLAST+: architecture and applications. BMC Bioinformatics 2009; 10:421 [View Article]
    [Google Scholar]
32. IBM CR. IBM SPSS Statistics for Windows, Version 25.0. Armonk, NY: IBM Corp; 2017
    [Google Scholar]
33. Sousa AM, Pereira MO. Pseudomonas aeruginosa diversification during infection development in cystic fibrosis lungs-a review. Pathogens 2014; 3:680–703 [View Article]
    [Google Scholar]
34. López-Causapé C, Cabot G, Del Barrio-Tofiño E, Oliver A. The versatile mutational resistome of Pseudomonas aeruginosa . Front Microbiol 2018; 9:685 [View Article]
    [Google Scholar]
35. Rehman A, Patrick WM, Lamont IL. Mechanisms of ciprofloxacin resistance in Pseudomonas aeruginosa: new approaches to an old problem. J Med Microbiol 2019; 68:1–10 [View Article]
    [Google Scholar]
36. Breidenstein EBM, de la Fuente-Núñez C, Hancock REW. Pseudomonas aeruginosa: all roads lead to resistance. Trends Microbiol 2011; 19:419–426 [View Article]
    [Google Scholar]
37. Chávez-Jacobo VM, Hernández-Ramírez KC, Romo-Rodríguez P, Pérez-Gallardo RV, Campos-García J et al. CrpP Is a novel ciprofloxacin-modifying enzyme encoded by the Pseudomonas aeruginosa pUM505 plasmid. Antimicrob Agents Chemother 2018; 62:e02629-17 [View Article]
    [Google Scholar]